Introduction: Several research have demonstrated the connection between lipid levels, diabetes mellitus (DM), and hypertension, but none focused specifically on association levels essential hypertension in Nepal's non-diabetic population.
 Aims: To study relationship profile, body mass index (BMI), blood pressure (BP) nondiabetic hypertensive Methods: A hospital-based cross-sectional was c...

BACKGROUND HIV infection has commonly been found to affect lipid profile and antioxidant defense. OBJECTIVES To determine the effects of Human Immunodeficiency Virus (HIV) infection and viral subtype on patient's cholesterol and oxidative stress markers, and determine whether in the absence of Highly Active Antiretroviral Therapy (HAART), these biochemical parameters could be useful in patien...

Background Patients with rheumatoid arthritis (RA) have an increased risk for developing cardiovascular diseases (CVD). This is partly due to the systemic inflammation characteristic disease, but also prevalence of ‘traditional’ factors such as dyslipidemia. The in RA often leads catabolism lipids, resulting a subsequent decrease HDL and LDL, while treatment anti-inflammatory medication reverse...

Background: This study was conducted to determine the effects of n-3 PUFAs supplementation on plasma homocysteine (Hcy) level, lipid profile and insulin resistance in patients with type 2 diabetes (T2D). Methods: This study is a double-blind controlled trial involving 70 patients with T2D selected from Yazd Diabetes Research Center in 2013. Patients were randomly assigned to receive either 2 g/...

This memo documents MAPOS 16, a multiple access protocol for transmission of network-protocol datagrams, encapsulated in HDLC frames with 16 bit addressing, over SONET/SDH. The primary difference with MAPOS version 1 is that it has 16 bit address field that offers significant wide address space. This document is NOT the product of an IETF working group nor is it a standards track document. It h...

Peroxisome proliferator-activated receptors (PPARs) are involved in the regulation of lipid and glucose metabolism. PPAR agonists improve insulin sensitivity and hyperglycemia and are effective in treating type 2 diabetes mellitus (T2DM), whereas PPAR agonists are used to treat dyslipidemia and atherosclerosis. The goal here was to examine the efficacy of a selective PPAR agonist {(S)-3-[3-(1-c...

INTRODUCTION Insulin resistance in latent autoimmune diabetes in adults (LADA) patients is controversial. The aim of this study was to evaluate insulin resistance and its related factors (metabolic syndrome parameters) among subjects with LADA and glutamic acid decarboxylase antibodies (GADA) negative diabetes, as well as the impact of these factors on insulin resistance. MATERIALS AND METHOD...